Augmented production of soluble CD93 in patients with systemic sclerosis and clinical association with severity of skin sclerosis
British Journal of Dermatology, 05/14/2012Yanaba K et al.
Serum soluble form of CD93 (sCD93) level is increased in patients with systemic sclerosis (SSc) and correlates with the severity and activity of skin sclerosis. CD93 may contribute to the development of skin fibrosis in SSc.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.